Multiple Sclerosis Clinical Trial

Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis

Summary

This study will assess the efficacy, safety, and tolerability of ACT-128800 in patients with relapsing-remitting multiple sclerosis.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adult males and females
Diagnosis of RRMS as defined by the revised (2005) McDonald Diagnostic Criteria for Multiple Sclerosis (MS).
Signed inform consent prior to initiation of any study-mandated procedure.

Exclusion Criteria:

A diagnosis of MS categorized as primary progressive or secondary progressive or progressive relapsing.
Patients currently treated for an autoimmune disorder other than MS.
Contraindications for MRI.
Ongoing bacterial, viral, or fungal infection.
History or presence of malignancy.

Additional inclusion and exclusion criteria apply with respect to medical conditions and concomitant treatments which could affect patients' risk from participating in the study.

Study is for people with:

Multiple Sclerosis

Phase:

Phase 2

Estimated Enrollment:

464

Study ID:

NCT01006265

Recruitment Status:

Completed

Sponsor:

Actelion

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 112 Locations for this study

See Locations Near You

Clinical Investigative Site 3132
Scottsdale Arizona, 85259, United States
Clinical Investigative Site 3100
Tucson Arizona, 85741, United States
Clinical Investigative Site 3115
Sacramento California, 95817, United States
Clinical Investigative Site 3117
Stanford California, 94305, United States
Clinical Invesigative Site 3116
Sarasota Florida, 34233, United States
Clinical Investigative Site 3101
Indianapolis Indiana, 46202, United States
Clinical Investigative Site 3105
Kansas City Kansas, 66160, United States
Clinical Investigative Site 3107
Lenexa Kansas, 66214, United States
Clinical Investigative Site 3118
Baltimore Maryland, 21201, United States
Clinical Investigative Site 3133
Worcester Massachusetts, 01605, United States
Clinical Investigator 3136
Saint Louis Missouri, 63100, United States
Clinical Investigative Site # 3135
Newark New Jersey, 07103, United States
Clinical Investigative Site 3129
Latham New York, 12110, United States
Clinical Investigative Site # 3128
New York New York, 10032, United States
Clinical Investigative Site 3127
Schenectady New York, 12308, United States
Clinical Investigative Site 3120
Stony Brook New York, 11794, United States
Clinical Investigative Site 3119
Raleigh North Carolina, 27607, United States
Clinical Investigator 3126
Akron Ohio, 44320, United States
Clinical Investigative Site 3113
Cincinnati Ohio, 45219, United States
Clinical Investigative Site 3130
Columbus Ohio, 43221, United States
Clinical Investigator 3104
Portland Oregon, 97225, United States
Clinical Investigative Site 3125
Philadelphia Pennsylvania, 19107, United States
Clinical Investigative Site 3112
Burlington Vermont, 05401, United States
Clinical Investigative Site 3111
Richmond Virginia, 23298, United States
Clinical Investigative Site 3102
Kirkland Washington, 98034, United States
Clinical Investigative Site # 1001
Fitzroy , 3065, Australia
Clinical Investigative Site 1000
Westmead , 2145, Australia
Clinical Investigative Site 1102
Amstetten , 3300, Austria
Clinical Investigative Site 1100
St Polten , 3100, Austria
Clinical Investigative Site 1101
Vienna , 1090, Austria
Clinical Investigative Site 1201
La Louviere , 7100, Belgium
Clinical Investigative Site # 1205
Liege , 4000, Belgium
Clinical Investigative Site 1204
Ottignies , 1340, Belgium
Clinical Investigative Site 1203
Sijsele-Damme , 8340, Belgium
Clinical Investigative Site 1302
Sofia , 1309, Bulgaria
Clinical Investigative Site 1301
Sofia , 1431, Bulgaria
Clinical Investigative Site 1303
Varna , 9010, Bulgaria
Clinical Investigative Site 1304
Varna , 9010, Bulgaria
Clinical Investigative Site 1401
Burbaby British Columbia, V5G 2, Canada
Clinical Investigative Site # 1401
Burnaby , V5G 2, Canada
Clinical Investigative Site 1400
Ottawa , K1H 8, Canada
Clinical Investigative Site 1502
Brno , 656 9, Czechia
Clinical Investigative Site 1506
Jihlava , 586 3, Czechia
Clinical Investigative Site 1504
Olomouc , 775 2, Czechia
Clinical Investigative Site 1501
Ostrava-Poruba , 70852, Czechia
Clinical Investigative Site 1500
Praha , 128 0, Czechia
Clinical Investigative Site 1503
Teplice , , Czechia
Clinical Investigative Site 1600
Helsinki , 00100, Finland
Clinical Investigative Site 1601
Hyvinkaa , 05800, Finland
Clinical Investigative Site 1603
Tampere , 33520, Finland
Clinical Investigative Site 1602
Turku , 20100, Finland
Clinical Investigative Site 1701
Montpellier Cedex , 34295, France
Clinical Investigative Site # 1806
Bayreuth , 95445, Germany
Clinical Investigative 1807
Berlin , 10117, Germany
Clinical Investigative Site 1803
Berlin , 13347, Germany
Clinical Investigative site 1800
Dusseldorf , 40225, Germany
Clinical Investigative Site 1802
Essen , 45147, Germany
Clinical Investigative Site 1805
Homburg/Saar , 66421, Germany
Clinical Investigative Site 1804
Ulm , 89081, Germany
Clinical Investigative Site 1905
Budapest , 1134, Hungary
Clinical Investigative Site # 1904
Budapest , H-111, Hungary
Clinical Investigative Site 1908
Budapest , H-114, Hungary
Clinical Investigative Site 1902
Gyor , 11-90, Hungary
Clinical Investigative Site 1900
Petofi , 2500, Hungary
Clinical Investigative Site 1901
Szentpeteri-Kapu , 3526, Hungary
Clinical Investigative Site 2000
Ashkelon , 78278, Israel
Clinical Investigative Site 2003
Tel-Aviv , 64239, Israel
Clinical Investigative Site 2001
Tel-Hashomer , 52621, Israel
Clinical Investigative Site 2002
Zerifin , 70300, Israel
Clinical Investigative Site 2101
Gallarte , 21013, Italy
Clinical Investigative Site 2104
Genova , 16132, Italy
Clinical Investigative Site # 2106
Milan , 20132, Italy
Clinical Investigative Site 2102
Padova , 35128, Italy
Clinical Investigative Site 2103
Roma , 00189, Italy
Clinical Investigative Site 2105
Siena , 53100, Italy
Clinical Investigative Site 2203
Breda , 4818, Netherlands
Clinical Investigative Site 2202
Nijmegen , 6533, Netherlands
Clinical Investigative Site 2201
Sittard-Geleen , 6162, Netherlands
Clinical Investigative Site 2305
Katowice , 47-75, Poland
Clinical Investigative Site 2303
Poznan , 60-35, Poland
Clinical Investigative Site 2304
Warsaw , 02-95, Poland
Clinical Investigative Site 2302
Wroclaw , 50-04, Poland
Clinical Investigative Site 2400
Bucuresti , 02290, Romania
Clinical Investigative Site 2401
Cluj-Napoca , 42806, Romania
Clinical Investigative Site 2402
Timisoara , 30073, Romania
Clinical Investigative Site # 3202
Moscow , 12701, Russian Federation
Clinical Investigative Site # 3203
Nizhniy Novgorod , 60315, Russian Federation
Clinical Investigative Site # 3206
Pyatigorsk , 35753, Russian Federation
Clinical Investigative Site # 3201
Samara , 44309, Russian Federation
Clinical Investigative Site 3209
Saratov , 41003, Russian Federation
Clinical Investigative Site # 3204
St. Petersburg , 19435, Russian Federation
Clinical Investigative Site 3201
St. Petersburg , 19702, Russian Federation
Clinical Investigative Site 3200
St. Petersburg , 19737, Russian Federation
Clinical Investigative Site 3208
Ufa , 45000, Russian Federation
Clinical Investigative Site 2501
Belgrade , 11000, Serbia
Clinical Investigative Site 2503
Kragujevac , 34000, Serbia
Clinical Investigative Site 2502
Nis , 18000, Serbia
Clinical Investigative Site 2706
Barcelona , 08035, Spain
Clinical Investigative Site 2702
Madrid , 28040, Spain
Clinical Investigative Site 2705
Madrid , 28222, Spain
Clinical Investigative Site 2701
Malaga , 29010, Spain
Clinical Investigative Site 2700
Sevilla , 41009, Spain
Clinical Investigative Site 2704
Valencia , 46009, Spain
Clinical Investigative Site 2802
Goteburg , 41345, Sweden
Clinical Investigative Site 2800
Stockholm , 17176, Sweden
Clinical Investigative Site 2801
Umed , 90185, Sweden
Clinical Investigative Site 2901
Lugano , CH-69, Switzerland
Clinical Investigative Site 2900
St Gallen , CH-90, Switzerland
Clinical Investigative Site 3302
Chernihiv , 14029, Ukraine
Clinical Investigative Site 3303
Dnipropetrovsk , 49044, Ukraine
Clinical Investigative Site 3300
Kyiv , 03110, Ukraine
Clinical Investigative Site 3304
Odesa , 65000, Ukraine
Clinical Investigative Site 3003
Bristol , BS16 , United Kingdom
Clinical Investigative Site 3004
Devon , PL6 S, United Kingdom
Clinical Investigative Site 3002
London , SE5 9, United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Phase:

Phase 2

Estimated Enrollment:

464

Study ID:

NCT01006265

Recruitment Status:

Completed

Sponsor:


Actelion

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider